Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,378 | 13,032 | 1,764 | 1,628 | 2,921 |
| TOTAL | $11,023 | $13,972 | $2,328 | $2,126 | $3,378 |
| Non-Current Assets | |||||
| PPE Net | 207 | 223 | 242 | 263 | 287 |
| Other Non-Current Assets | 48 | 48 | 48 | 48 | 48 |
| TOTAL | $255 | $271 | $290 | $311 | $334 |
| Total Assets | $11,278 | $14,243 | $2,618 | $2,437 | $3,712 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,196 | 509 | 1,151 | 632 | 867 |
| Accrued Expenses | 206 | 771 | 626 | 205 | 443 |
| TOTAL | $1,459 | $1,327 | $1,884 | $1,005 | $1,368 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,608 | 2,344 | 2,081 | 1,825 | 1,578 |
| TOTAL | $2,903 | $2,654 | $2,405 | $2,039 | $1,729 |
| Total Liabilities | $4,362 | $3,980 | $4,289 | $3,044 | $3,096 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 767 | 763 | 390 | 312 | 310 |
| Common Shares | 23 | 23 | 12 | 9 | 9 |
| Retained earnings | -156,544 | -152,465 | -149,261 | -144,264 | -141,999 |
| Other shareholders' equity | 32 | 32 | 32 | 32 | 32 |
| TOTAL | $6,917 | $10,263 | $-1,672 | $-607 | $616 |
| Total Liabilities And Equity | $11,278 | $14,243 | $2,618 | $2,437 | $3,712 |